Hubei Minkang Pharmaceutical LTD (HBMK) Financial Statements (2023 and earlier)

Company Profile

Business Address 55 UBI AVE, #03-01
MINTWELL BUILDING, 408864
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2014
MRQ
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 6,2346,073
Cash and cash equivalents 6,2346,073
Receivables 9561,616
Inventory, net of allowances, customer advances and progress billings 3,9853,221
Inventory 3,9853,221
Advances on inventory purchases 576484
Deposits current assets 589 
Prepaid expense and other current assets39
Other current assets 1,575
Other undisclosed current assets 6851,765
Total current assets: 14,59913,199
Noncurrent Assets
Property, plant and equipment 4,7404,848
Other undisclosed noncurrent assets 2,2762,445
Total noncurrent assets: 7,0167,293
TOTAL ASSETS: 21,61520,491
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 2,2783,404
Taxes payable  176
Accounts payable 2,2783,228
Debt 3,2723,170
Other liabilities 393434
Other undisclosed current liabilities 4,2452,530
Total current liabilities: 10,1889,538
Noncurrent Liabilities
Total liabilities: 10,1889,538
Equity
Equity, attributable to parent 11,42710,953
Common stock 5252
Additional paid in capital 5,8245,824
Accumulated other comprehensive income 1,7181,371
Retained earnings 3,8333,706
Total equity: 11,42710,953
TOTAL LIABILITIES AND EQUITY: 21,61520,491

Income Statement (P&L) ($ in thousands)

9/30/2014
TTM
12/31/2013
12/31/2012
Revenues 14,74313,919
Cost of revenue
(Cost of Goods and Services Sold)
 (8,314)(7,163)
Other undisclosed gross profit (139) 
Gross profit: 6,2896,756
Operating expenses (6,555)(5,898)
Other undisclosed operating income 308167
Operating income: 421,024
Nonoperating income (expense) 32(70)
Investment income, nonoperating 3122
Other nonoperating expense (12)(24)
Interest and debt expense (221)(237)
Other undisclosed income from continuing operations before equity method investments, income taxes 221237
Income from continuing operations before income taxes: 73955
Income tax benefit 546
Income from continuing operations: 127961
Income before gain (loss) on sale of properties: 127961
Net income available to common stockholders, diluted: 127961

Comprehensive Income ($ in thousands)

9/30/2014
TTM
12/31/2013
12/31/2012
Net income: 127961
Comprehensive income: 127961
Other undisclosed comprehensive income, net of tax, attributable to parent 34768
Comprehensive income, net of tax, attributable to parent: 4741,030

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: